GDP Non-Compliance Report: No Responsible Pharmacist
Recommendation

Tuesday, 29 September 2026 14.00 - 16.00 h
GDP-compliant Transport Processes: from Risk Assessment to Practical Implementation
The French National Agency for the Safety of Medicines and Health Products (Agence nationale de sécurité du médicament et des produits de santé, ANSM) has posted a new Statement of Non-Compliance with GDP in the EudraGMDP database. The statement dated 21 August 2025, concerning a wholesale distributor located in Chambly, France, is the result of an inspection conducted on 07 July 2025.
According to the report, the company's responsible pharmacist and deputy ceased their activities on 26 September and 03 October 2024 respectively. The company failed to appoint replacements or notify ANSM accordingly.
The authority writes that the company "has not demonstrated that it has brought its pharmaceutical establishment into compliance, and the serious deficiencies of current regulations persist."
As regulatory action, the wholesale authorisation was suspended.
Source: EudraGMDP Database (Inspection Date: 07 July 2025; Report Number: 2025_NCS_FR_002). *
* To find the respective report, please click on "Non-Compliance Reports" in the menu on the left-hand side and select in "From Date / To Date" the month the inspection took place. After clicking on "Search" the results list will be displayed, from which you can choose the report with the number mentioned above.
Related GMP News
10.09.2026European GDP Association Developments May through August 2026
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September
10.09.2026GDP in the US: FDA Launches DSCSA Assessment for Small Dispensers and Issues Exemptions
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations


